Complete Filing Data
Translational Development Acquisition Corp. reported Stockholders Equity of -$6.54 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Translational Development Acquisition Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income * | $6.4M | -$71.0K | -$485.6K |
| Operating Income Loss | -$944.5K | -$196.4K | -$485.6K |
| General And Administrative Expense | $944.5K | $196.4K | |
| Nonoperating Income Expense | $7.3M | $125.3K | |
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Net Income * | $1.7M | $1.6M | $1.5M | -$61.3K | -$1.7K | $0.00 |
| Operating Income Loss | -$213.7K | -$221.1K | -$347.4K | -$61.3K | -$1.7K | $0.00 |
| General And Administrative Expense | $213.7K | $221.1K | $347.4K | $61.3K | $1.7K | $0.00 |
| Nonoperating Income Expense | $1.9M | $1.8M | $1.8M | $0.00 | ||
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | $1.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | -$6.5M | -$5.6M | -$507.7K | -$22.1K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $29.8K | $438.2K | $2.0K | $2.2K |
| Retained Earnings Accumulated Deficit | -$6.5M | -$5.6M | -$532.7K | |
| Liabilities Current | $544.1K | $210.3K | $509.7K | |
| Liabilities And Stockholders Equity | $181.7M | $175.0M | $2.0K | |
| Liabilities | $6.6M | $6.2M | $509.7K | |
| Cash And Cash Equivalents At Carrying Value | $29.8K | $438.2K | $2.0K | |
| Assets Held In Trust Noncurrent | $181.7M | $174.4M | $0.00 | |
| Assets Current | $39.5K | $650.2K | $2.0K | |
| Assets | $181.7M | $175.0M | $2.0K | |
| Accrued Offering Costs | $75.0K | $192.1K | $160.9K | |
| Other Liabilities Current | $106.8K | $2.0K | ||
| Deferred Underwriting Fee Noncurrent | $6.0M | $6.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$408.4K | $436.2K | -$204.00 | |
| Accounts Payable And Accrued Liabilities Current | $162.3K | $16.2K | ||
| Accretion Of Temporary Equity To Redemption Value Adjustments | $7.3M | |||
| Marketable Securities Unrealized Gain Loss | $7.3M | $125.3K | ||
| Deferred Offering Costs Paid Through Promissory Note | $41.2K | $88.5K | ||
| Offering Costs Included In Accrued Offering Costs | $495.9K | $5.8K | ||
| Deferred Underwriting Fee | $6.0M | |||
| Notes Payable Current | $200.0K | $347.5K | ||
| Temporary Equity Accretion To Redemption Value | $13.1M | |||
| Repayments Of Related Party Debt | $800.0K | |||
| Accounts Payable Current | $16.2K | $1.3K | ||
| Deferred Offering Cost Write Off | $482.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$6.4M | -$6.2M | -$5.9M | -$570.6K | -$509.3K | -$507.7K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $47.2K | $35.3K | $206.6K | $224.0K | $72.0K | |
| Retained Earnings Accumulated Deficit | -$6.4M | -$6.2M | -$5.9M | |||
| Liabilities Current | $422.8K | $284.7K | $322.9K | |||
| Liabilities And Stockholders Equity | $180.0M | $178.2M | $176.6M | |||
| Liabilities | $6.5M | $6.3M | $6.4M | |||
| Cash And Cash Equivalents At Carrying Value | $47.2K | $35.3K | $206.6K | |||
| Assets Held In Trust Noncurrent | $179.9M | $178.0M | $176.2M | |||
| Assets Current | $80.6K | $156.1K | $415.4K | |||
| Assets | $180.0M | $178.2M | $176.6M | |||
| Accrued Offering Costs | $75.0K | $75.0K | $75.0K | |||
| Other Liabilities Current | $76.8K | $46.8K | $22.4K | |||
| Deferred Underwriting Fee Noncurrent | $6.0M | $6.0M | $6.0M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$231.6K | |||||
| Accounts Payable And Accrued Liabilities Current | $171.1K | $162.9K | $225.5K | |||
| Accretion Of Temporary Equity To Redemption Value Adjustments | $1.9M | $1.8M | $1.8M | |||
| Marketable Securities Unrealized Gain Loss | ||||||
| Deferred Offering Costs Paid Through Promissory Note | ||||||
| Offering Costs Included In Accrued Offering Costs | ||||||
| Deferred Underwriting Fee | ||||||
| Notes Payable Current | $100.0K | |||||
| Temporary Equity Accretion To Redemption Value | ||||||
| Repayments Of Related Party Debt | ||||||
| Accounts Payable Current | ||||||
| Deferred Offering Cost Write Off |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Increase Decrease In Accounts Payable And Accrued Liabilities | $29.0K | -$449.7K | $1.0K |
| Net Cash Provided By Used In Operating Activities | -$608.4K | -$851.4K | -$204.00 |
| Proceeds From Related Party Debt | $200.0K | $406.5K | |
| Net Cash Provided By Used In Financing Activities | $200.0K | $175.5M | |
| Increase Decrease In Due From Related Parties | -$104.8K | -$2.0K | |
| Increase Decrease In Prepaid Expense And Other Current Assets | |||
| Increase Decrease In Prepaid Expense | -$202.4K | $212.1K | -$2.0K |
| Payments Of Stock Issuance Costs | $218.9K | ||
| Proceeds From Issuance Of Private Placement | $7.1M | ||
| Payments To Acquire Investments | $174.2M | ||
| Net Cash Provided By Used In Investing Activities | -$174.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 |
|---|---|
| Increase Decrease In Accounts Payable And Accrued Liabilities | $92.2K |
| Net Cash Provided By Used In Operating Activities | -$231.6K |
| Proceeds From Related Party Debt | |
| Net Cash Provided By Used In Financing Activities | |
| Increase Decrease In Due From Related Parties | -$20.4K |
| Increase Decrease In Prepaid Expense And Other Current Assets | -$3.2K |
| Increase Decrease In Prepaid Expense | |
| Payments Of Stock Issuance Costs | |
| Proceeds From Issuance Of Private Placement | |
| Payments To Acquire Investments | |
| Net Cash Provided By Used In Investing Activities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Investment Income Dividend | $7.3M | $125.3K | |
| Prepaid Expense Current | $9.7K | $212.1K | |
| Other Offering Costs | $756.1K | ||
| Sale Of Stock Consideration Received On Transaction | $169.1M | ||
| Payment Of Operating Cost Through Issuance Of Promissory Note | $4.7K | ||
| Operating And Formation Costs | $196.4K | $485.6K | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $96.2K | ||
| Additional Paid In Capital | $24.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q1 2024 |
|---|---|---|---|---|
| Investment Income Dividend | $1.9M | $1.8M | $1.8M | $0.00 |
| Prepaid Expense Current | $33.4K | $120.8K | $208.8K | |
| Other Offering Costs | ||||
| Sale Of Stock Consideration Received On Transaction | ||||
| Payment Of Operating Cost Through Issuance Of Promissory Note | ||||
| Operating And Formation Costs | ||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | ||||
| Additional Paid In Capital |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.